Report copyright - Resverlogix Corp. Corporate Presentation118009.choruscall.com/resverlogix/resverlogix20210204.pdfTrial Size 3,600 patients Basic Trial Design • Type 2 Diabetes patients post ACS
Please pass captcha verification before submit form
Please pass captcha verification before submit form